Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score

Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of  v 6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence

(2013) M. D. Allen et al.   CLINICAL CANCER RESEARCH

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

(2013) L. J. Solin et al.   JNCI-Journal of the National Cancer Institute

Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

(2013) Catherine F. Cowell et al.   Molecular Oncology

Association of the Glutathione S-Transferase M1, T1 Polymorphisms with Cancer: Evidence from a Meta-Analysis

(2013) Jianzheng Fang et al.   PLoS One

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

(2012) Sara A. Lari et al.   Journal of Cancer

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

(2011) I. L. Wapnir et al.   JNCI-Journal of the National Cancer Institute

Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: A comparison with ECOG study 5194

(2010) Sabin B. Motwani et al.   CANCER

Post-operative radiotherapy for ductal carcinoma in situ of the breast – A systematic review of the randomised trials

(2009) Annabel Goodwin et al.   BREAST

Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group

(2009) Lorie L. Hughes et al.   JOURNAL OF CLINICAL ONCOLOGY